Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, Kazuya Sugimori et al.|Journal of Clinical Oncology|2013Cited by 632
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)Fuyuhiko Motoi, Tomoo Kosuge, Hideki Ueno et al.|Japanese Journal of Clinical Oncology|2018Cited by 534
RNF126 as a Marker of Prognosis and Proliferation of Gastric CancerKazuhiro Migita, Masayuki Sho|Anticancer Research|2020Cited by 26
Quantitative evaluation of tumor signal heterogeneity on gadoxetic acid‐enhanced magnetic resonance imaging as a predictor of postoperative survival and antitumor immunity in hepatocellular carcinomaShunsuke Doi, Masayuki Sho|Hepatology Research|2025Cited by 0